U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO Guidelines for malaria [Internet]. Geneva: World Health Organization; 2022 Feb 18.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of WHO Guidelines for malaria

WHO Guidelines for malaria [Internet].

Show details

1ABBREVIATIONS

Anti-CS

Anti circumsporozoite antibody

ACT

artemisinin-based combination therapy

AE

Adverse Event

AEFI

Adverse Event Following Immunization

AESI

Adverse Event of Special Interest

ANC

antenatal care

AVPU

Alert, Voice, Pain, Unresponsive

BCC

behaviour change communication

bw

body weight

CI

confidence interval

CIDG

Cochrane Infectious Diseases Group

DALY

disability adjusted life year

DHIS2

District Health Information Software 2

DTP

diphtheria, tetanus and pertussis (vaccine)

EIR

entomological inoculation rate

EPI

Expanded Programme on Immunization

EtD

evidence to decision framework

GDG

Guidelines Development Group

GMP

Global Malaria Programme

GPIRM

Global plan for insecticide resistance management

GRADE

Grading of Recommendations Assessment, Development and Evaluation

GTS

Global technical strategy for malaria 2016 - 2030

G6PD

glucose-6-phosphate dehydrogenase

HBHI

High burden to high impact approach

HRP2

histidine-rich protein 2

ICER

incremental cost-effectiveness ratio

IPTi

intermittent preventive treatment in infants

IPTp

intermittent preventive treatment in pregnancy

IRM

insecticide resistance management

IRS

indoor residual spraying

IOS

International Organization for Standardization

ITN

insecticide-treated net

ITPS

insecticide-treated plastic sheeting

IVB

WHO Department for Immunization, Vaccines and Biologicals

IVM

integrated vector management

LLIN

long-lasting insecticidal net

LSM

larval source management

M&E

monitoring and evaluation

MPAG

Malaria Policy Advisory Group (previously Malaria Policy Advisory Committee)

MVIP

WHO Malaria Vaccine Implementation Programme

NAAT

nucleic acid amplification test

NMP

national malaria programme

NSP

national (malaria) strategic plan

PBO

piperonyl butoxide

PCR

polymerase chain reaction

PfHRP2

Plasmodium falciparum histidine-rich protein-2

PICO

population, participants or patients; intervention or indicator; comparator or control; outcome

PPC

preferred product characteristic

PQ

prequalification (WHO)

pLDH

parasite-lactate dehydrogenase

Pvdhfr

Plasmodium vivax dihydrofolate reductase gene

PYAR

person-years at risk

QC

quality control

RCT

randomized controlled trial

RDT

rapid diagnostic test

RR

relative risk, or risk ratio

SP

sulfadoxine–pyrimethamine

SP + AQ

sulfadoxine-pyrimethamine + amodiaquine

SMC

seasonal malaria chemoprevention

TES

therapeutic efficacy study

VCAG

Vector Control Advisory Group

VCTEG

Technical Expert Group on Malaria Vector Control

WHO

World Health Organization

© World Health Organization 2022.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons AttributionNonCommercial-ShareAlike 3.0 IGO license (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this license, you may copy, redistribute and adapt the work for noncommercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons license. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Bookshelf ID: NBK579028

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...